Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06557057 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

StatusRecruiting
PhaseNot specified
Started2023-11-16
View on ClinicalTrials.gov ↗

Amendment history

2026-09-01
Study Status, Study Design v6
Enrollment increased: 66 → 81 participants
2026-03-26
Study Identification, Study Status, Study Description, Eligibility v5
Study description+58 characters
[...] bitors in women with hormone receptor positive breast cancer or, ductal carcinoma in situ (cancer, DCIS ), or women with other high risk breast conditions, on various indices of glucose homeostasis, utilizing oral m [...]
2026-02-20
Study Status, Study Design, Eligibility v4
Enrollment target75→66
Eligibility criteria+41 characters
Inclusion Criteria: Post-menopausal women with hormone receptor positive breast cancer or, ductal carcinoma in situ (DCIS), or with other high risk breast conditions. Post-menopause will be defined as women who experience 12 [...]
2025-09-16
Study Status, Study Description, Outcome Measures, Eligibility v3
Primary endpoints3 entries, revised
DIDisposition Index (disposition indexDI)
Study description+60 characters
[...] rs in women with hormone receptor positive breast cancer or ductal carcinoma in situ (DCIS,) on various indices of glucose homeostasis, utilizing oral m [...] Patients undergo blood sample collection, glucose testing, dual-energy x-ray absorptiometry (DEXA)scan to measure body composition, complete a questionnaire and have their medical records reviewed on study.
2025-09-03
Study Status, Oversight, Study Description, Outcome Measures, Eligibility, Contacts/Locations v2
Primary completion date2025-12-01→2026-12-01
Completion date2025-12-01→2026-12-01
Eligibility criteria+35 characters
Inclusion Criteria: Post-menopausal women with hormone receptor positive breast cancer or ductal carcinoma in situ (DCIS). Post-menopause will be defined as women who experience 12 [...]
Study description+8 characters
[...] bitors in women with hormone receptor positive breast cancer or DCIS, on various indices of glucose homeostasis, utilizing oral [...]
Study sitescontacts updated at 1 of 1 site
2024-09-19
Study Status, Oversight, Study Design, Contacts/Locations v1
Study sitescontacts updated at 1 of 1 site
2024-08-13
Original filing
Mayo Clinic
1,015 trials monitored
See 115 trials at risk
Breast Cancer
5,180 trials monitored
See 256 trials at risk
HER2-Positive Cancer
324 trials monitored
See 21 trials at risk
This study assesses the effect of hormone directed treatment for breast cancer on glucose metabolism.
Trial Details
NCT Number NCT06557057
Lead Sponsor Mayo Clinic
Conditions HER2-Positive Breast Carcinoma
Enrollment 81 participants
Start Date 2023-11-16
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-02